Apelin and its receptor APJ in human aortic valve stenosis

Journal of Heart Valve Disease

Volumn 18, Issue 6, 2009, Pages 644-652

  Peltonen, Tuomas ^a   Näpänkangas, Juha ^a   Vuolteenaho, Olli ^a   Ohtonen, Pasi ^b   Soirti, Ylermi ^a   Juvonen, Tatu ^b   Satta, Jari ^b   Ruskoaho, Heikki ^a   Taskinen, Panu ^b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGTRL1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; APLN PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; SIGNAL PEPTIDE;

ADULT; AGED; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; CALCINOSIS; CASE CONTROL STUDY; DOWN REGULATION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 77449127422     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-3326 (Pubitemid 40875006)
2. Hakuno D, Kimura N, Yoshioka M, Fukuda K. Molecular mechanisms underlying the onset of degenerative aortic valve disease. J Mol Med 2009;87:17-24
3. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-2270 (Pubitemid 27191003)
4. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-925 (Pubitemid 40279895)
5. Lee DK, George SR, O'Dowd BE. Unravelling the roles of the apelin system: Prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci 2006;27:190-194
6. Quertermous T. Apelin and its G protein-coupled receptor regulate cardiac development as well as cardiac function. Dev Cell 2007;12:319-320
7. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 2008;10:725-732
8. Kalin RE, Kretz MP, Meyer AM, Kispert A, Heppner FL, Brandli AW. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 2007;305:599-614 (Pubitemid 46686624)
9. Sorli SC, Le Gonidec S, Knibiehler B, Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007;26:7692-7699 (Pubitemid 350224216)
10. Chun HJ, Ali ZA, Kojima Y, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008;118:3343-3354
11. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-472
12. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34 (Pubitemid 30127593)
13. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-657
14. Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 1999;100:2093-2099 (Pubitemid 29532061)
15. Tsutsumi Y, Matsubara H, Ohkubo N, et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998;83:1035-1046 (Pubitemid 28520933)
16. Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol 2004;44:1859-1866 (Pubitemid 39424087)
17. Peltonen TO, Taskinen P, Soini Y, et al. Distinct downregulation of C-type natriuretic peptide systern in human aortic valve stenosis. Circulation 2007;116:1283-1289 (Pubitemid 47517540)
18. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225 (Pubitemid 23106200)
19. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147 (Pubitemid 29325741)
20. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634 (Pubitemid 27116107)
21. Saint-Geniez M, Masri B, Malecaze F, Knibiehler B, Audigier Y. Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels. Mech Dev 2002;110:183-186 (Pubitemid 34020638)
22. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006;296:177-189 (Pubitemid 44061763)
23. Helske S, Oksjoki R, Lindstedt KA, et al. Complement system is activated in stenotic aortic valves. Atherosclerosis 2008;196:190-200
24. Eyries M, Siegfried G, Ciumas M, et al. Hypoxiainduced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 2008;103:432-440
25. Kasai A, Shintani N, Oda M, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004;325:395-400 (Pubitemid 39458008)
26. Tang SY, Xie H, Yuan LQ, et al. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways. Peptides 2007;28:708-718 (Pubitemid 46204990)
27. Xie H, Yuan LQ, Luo XH, et al. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 2007;12:247-254 (Pubitemid 46009517)
28. O'Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993;136:355-360 (Pubitemid 24049270)
29. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000;74:34-41 (Pubitemid 30012752)
30. 1Apelin-l3 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 2001;132:1255-1260 (Pubitemid 32234709)
31. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-2230 (Pubitemid 35222217)